Literature DB >> 12061670

Does early erythropoietin therapy decrease transfusions in anemia of prematurity?

Begüm Atasay1, Ayla Günlemez, Nejat Akar, Saadet Arsan.   

Abstract

OBJECTIVE: To investigate the effect of early erythropoietin treatment on induction of erythropoiesis and the need for transfusion in Very Low Birth Weight (VLBW) infants with acute neonatal problems.
METHODS: The study group consisted of 14 VLBW prematures with gestational ages less than 32 weeks who were given subcutaneous erythropoietin (600 U/kg per week) and oral iron (3 mg/kg per day) during the first 7-8 weeks of their life, while 13 other VLBW prematures that were given placebo constituted the control group. Weekly hematocrit, (Hct) reticulocyte (Ret) values and the volume of blood drawn and transfused were recorded in the both groups.
RESULTS: The groups were comparable regarding with birth weights and gestational ages. The volume of the blood drawn (76.8 +/- 42.5 and 37.0 +/- 15.2) was higher and the volume of the transfusions (51.84 +/- 49.30 and 68.84 +/- 41.2) was lower in the study group but the differences between the groups were not significant (p>0.05). The hematocrit, the reticulocyte and the ferritin values were similar in both the groups at the end of the therapy.
CONCLUSION: Under the neonatal intensive care circumstances of developing countries where blood volumes needed for laboratory analysis are still very high, phlebotomy losses can not be avoided. Thus early erythropoietin and iron therapy at these doses are not effective in decreasing the need for transfusion and induction of endogenous erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061670     DOI: 10.1007/bf02722624

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  11 in total

1.  Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity.

Authors:  E C Vamvakas; R G Strauss
Journal:  Transfusion       Date:  2001-03       Impact factor: 3.157

2.  Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.

Authors:  R K Ohls; R D Christensen
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

3.  Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea.

Authors:  R G Strauss
Journal:  J Pediatr       Date:  1997-11       Impact factor: 4.406

Review 4.  The role of erythropoietin in the anemia of prematurity.

Authors:  J J Doyle
Journal:  Semin Perinatol       Date:  1997-02       Impact factor: 3.300

Review 5.  Assessment of anemia in newborn infants.

Authors:  V S Blanchette; A Zipursky
Journal:  Clin Perinatol       Date:  1984-06       Impact factor: 3.430

6.  Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.

Authors:  K M Shannon; W C Mentzer; R I Abels; P Freeman; N Newton; D Thompson; S Sniderman; R Ballard; R H Phibbs
Journal:  J Pediatr       Date:  1991-06       Impact factor: 4.406

7.  Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates.

Authors:  E A Liu; F L Mannino; T A Lane
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

8.  Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells.

Authors:  D A Lee; T A Slagle; T M Jackson; C S Evans
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

9.  The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.

Authors:  R F Maier; M Obladen; P Scigalla; O Linderkamp; G Duc; G Hieronimi; H L Halliday; H T Versmold; G Moriette; G Jorch
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

10.  Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.

Authors:  V Soubasi; G Kremenopoulos; E Diamanti; C Tsantali; K Sarafidis; D Tsakiris
Journal:  J Pediatr       Date:  1995-08       Impact factor: 4.406

View more
  3 in total

1.  Erythropoietin in anemia of prematurity.

Authors:  Suraj Gupte
Journal:  Indian J Pediatr       Date:  2003-03       Impact factor: 1.967

2.  Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.

Authors:  Sanjay M Aher; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2019-02-15

3.  Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.

Authors:  Sanjay M Aher; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2020-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.